Literature DB >> 7907663

Circulating HIV-1-infected cell burden from seroconversion to AIDS: importance of postseroconversion viral load on disease course.

T H Lee1, H W Sheppard, M Reis, D Dondero, D Osmond, M P Busch.   

Abstract

The purpose of this study was to characterize quantitative changes in circulating infected cells over the natural history of human immunodeficiency virus (HIV) disease in relation to clinical/immunological outcome. HIV-1 gag DNA polymerase chain reaction (PCR) and peripheral blood mononuclear cell (PBMC) co-cultures were performed on limiting dilutions of cryopreserved PBMC from specimens collected at enrollment and after 5 years of follow-up from nine seropositive subjects classified as rapid progressors, nine intermediate progressors, and 10 nonprogressors. Limiting dilution PCR was also performed on serial pre/postseroconversion specimens from 18 seroconvertors. By quantitative DNA PCR analysis, the infected cell burden was significantly higher at enrollment in the RP [mean of 330 PCR units (PCRU)/10(6) PBMCs] than in the IP (160 PCRU/10(6) PBMCs) and NP (73 PCRU/10(6) PBMCs) groups (p = 0.05). When results were analyzed on an individual level with proportional hazard regression, baseline PCRU (p = 0.05) and CD4 slope (p = 0.0007) were significantly associated with developing acquired immune deficiency syndrome (AIDS) in 5 years, but baseline tissue culture infectious units (TCIU) was not. The increase in PCR-positive cells after 5 years was modest in all three groups (two- to fivefold), whereas the proportion of PCR-positive cells that yielded virus in culture increased significantly (21- to 31-fold) over time in all three groups. Infected cell burden in postseroconversion specimens was relatively stable within each subject, but varied greatly (from 1.6 to 1,024 PCRU/10(6) PBMCs) among subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7907663

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  15 in total

1.  HIV and aerobic exercise. Current recommendations.

Authors:  W W Stringer
Journal:  Sports Med       Date:  1999-12       Impact factor: 11.136

2.  Whole body positron emission tomography imaging of simian immunodeficiency virus-infected rhesus macaques.

Authors:  A M Scharko; S B Perlman; J M Hanson; H Uno; C D Pauza
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS.

Authors:  E L Delwart; H Pan; H W Sheppard; D Wolpert; A U Neumann; B Korber; J I Mullins
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 4.  AIDS and the lung: update 1995. 4. Role of the human immunodeficiency virus within the lung.

Authors:  J R Clarke; D S Robinson; R J Coker; R F Miller; D M Mitchell
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

5.  Human immunodeficiency virus-1 (HIV-1) gp120 superantigen-binding serum antibodies. A host factor in homosexual HIV-1 transmission.

Authors:  J Townsley-Fuchs; L Kam; R Fairhurst; S J Gange; L Goodglick; J V Giorgi; N Sidell; R Detels; J Braun
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

6.  Differential effects of interleukin-12, interleukin-15, and interleukin-2 on human immunodeficiency virus type 1 replication in vitro.

Authors:  M Bayard-McNeeley; H Doo; S He; A Hafner; W D Johnson; J L Ho
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

7.  Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.

Authors:  R I Connor; B T Korber; B S Graham; B H Hahn; D D Ho; B D Walker; A U Neumann; S H Vermund; J Mestecky; S Jackson; E Fenamore; Y Cao; F Gao; S Kalams; K J Kunstman; D McDonald; N McWilliams; A Trkola; J P Moore; S M Wolinsky
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

8.  Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons.

Authors:  M Vesanen; C E Stevens; P E Taylor; P Rubinstein; K Saksela
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

9.  Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus.

Authors:  N L Michael; G Chang; L A d'Arcy; P K Ehrenberg; R Mariani; M P Busch; D L Birx; D H Schwartz
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

10.  Rapid culture and quantitation of human immunodeficiency virus type 1 from patient cells without the use of mitogen-stimulated donor cells.

Authors:  P K Kim; S He; J L HO
Journal:  Clin Diagn Lab Immunol       Date:  1994-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.